1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone and 2-(2-(5-bromo-1h-indol-3-yl)ethyl)-3-(1-methylethoxyphenyl)-4-(3h)-quinazolinone

1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone has been researched along with 2-(2-(5-bromo-1h-indol-3-yl)ethyl)-3-(1-methylethoxyphenyl)-4-(3h)-quinazolinone in 1 studies

Compound Research Comparison

Studies (1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone)	Trials (1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone)	Recent Studies (post-2010) (1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone)	Studies (2-(2-(5-bromo-1h-indol-3-yl)ethyl)-3-(1-methylethoxyphenyl)-4-(3h)-quinazolinone)	Trials (2-(2-(5-bromo-1h-indol-3-yl)ethyl)-3-(1-methylethoxyphenyl)-4-(3h)-quinazolinone)	Recent Studies (post-2010) (2-(2-(5-bromo-1h-indol-3-yl)ethyl)-3-(1-methylethoxyphenyl)-4-(3h)-quinazolinone)
26	0	5	25	0	10

Protein Interaction Comparison

Protein	Taxonomy	1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone (IC50)	2-(2-(5-bromo-1h-indol-3-yl)ethyl)-3-(1-methylethoxyphenyl)-4-(3h)-quinazolinone (IC50)
Gastrin/cholecystokinin type B receptor	Homo sapiens (human)		0.1205
Gastrin/cholecystokinin type B receptor	Mus musculus (house mouse)		0.0093

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Farook, JM; Lee, L; Moochhala, SM; Wang, Q; Wong, PT; Zhu, YZ	1

Other Studies

1 other study(ies) available for 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone and 2-(2-(5-bromo-1h-indol-3-yl)ethyl)-3-(1-methylethoxyphenyl)-4-(3h)-quinazolinone

Article	Year
Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus. Neuroscience letters, 2004, Apr-01, Volume: 358, Issue:3 Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Benzodiazepines; Brain; Chemokines; Chemokines, CC; Cholecystokinin; Male; Maze Learning; Proglumide; Pyrazoles; Quinazolines; Quinazolinones; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Species Specificity; Tetragastrin	2004

Article

Year

Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus.

Neuroscience letters, 2004, Apr-01, Volume: 358, Issue:3

Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Benzodiazepines; Brain; Chemokines; Chemokines, CC; Cholecystokinin; Male; Maze Learning; Proglumide; Pyrazoles; Quinazolines; Quinazolinones; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Species Specificity; Tetragastrin

2004